Accelerate Drug Discovery with High-Content, High-Throughput Imaging Solutions
A vast range of assays that we run on kidney, retina and lung models are visualised in our state-of-the-art imaging suite, which offers High-content imaging (HCI) capabilities, enhanced sensitivity and resolution to provide high-quality images and data that support accurate quantitative analyses.
Assays include:
With automated high-throughput screening (HTS) capabilities, and laser-based imaging system, the analysis process is accelerated, handling up to 1536-well plates with exceptional speed. You can leverage automated workflows to improve accuracy and standardisation of experiments, obtaining consistent, high-quality outputs for your drug discovery and development needs.
For complex cell models and tissue analysis, the Zeiss Axio Observer with Apotome 3 system, offers high-resolution imaging with optical sectioning for fluorescence-based studies.
ImageXpress® Pico Automated Cell Imaging system from Molecular Devices enables high-throughput imaging for fast and efficient drug screening.
The ImageXpress® Confocal HT.ai High-Content Imaging system combines high-throughput, high-content, and high-sensitivity imaging in one platform. This platform’s heightened sensitivity makes it excellent for finding active target molecules, collecting bias-free data and expediting research with confident decision-making and strong data.
